Eledon Pharmaceuticals (ELDN) Cash from Operations (2016 - 2017)
Historic Cash from Operations for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q3 2017 value amounting to -$3.4 million.
- Eledon Pharmaceuticals' Cash from Operations fell 13103.45% to -$3.4 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$13.6 million, marking a year-over-year decrease of 873.94%. This contributed to the annual value of -$47.3 million for FY2024, which is 1959.17% down from last year.
- Per Eledon Pharmaceuticals' latest filing, its Cash from Operations stood at -$3.4 million for Q3 2017, which was down 13103.45% from -$8.0 million recorded in Q2 2017.
- In the past 5 years, Eledon Pharmaceuticals' Cash from Operations ranged from a high of $7.6 million in Q2 2016 and a low of -$11.1 million during Q1 2015
- Over the past 5 years, Eledon Pharmaceuticals' median Cash from Operations value was -$5.9 million (recorded in 2014), while the average stood at -$5.4 million.
- Per our database at Business Quant, Eledon Pharmaceuticals' Cash from Operations soared by 16885.96% in 2016 and then plummeted by 20597.78% in 2017.
- Eledon Pharmaceuticals' Cash from Operations (Quarter) stood at -$6.8 million in 2013, then increased by 5.29% to -$6.5 million in 2014, then tumbled by 37.41% to -$8.9 million in 2015, then surged by 85.56% to -$1.3 million in 2016, then tumbled by 166.54% to -$3.4 million in 2017.
- Its last three reported values are -$3.4 million in Q3 2017, -$8.0 million for Q2 2017, and -$882000.0 during Q1 2017.